Skip to the page

Data / Drug companies / Estradiol

Estradiol: 53 companies and 250 products in the FDA NDC directory

Estradiol is listed in the FDA National Drug Code Directory by 53 companies, with 250 products in commercial distribution. 199 of the products (79.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; patch; patch, extended release, and the newest product started marketing on May 13, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
53
Products
250
Generic (ANDA) products
199 (79.6%)
Application numbers
35
Routes
Transdermal, Oral, Topical, Vaginal
Brand names
Dotti, Climara, Vivelle-Dot, Divigel, Lyllana, Minivelle, Estrace, Menostar
openFDA record search
api.fda.gov

Companies that list estradiol

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
A-S Medication Solutions21tablet; patchGeneric drugs (ANDA)July 10, 2024
Mylan Pharmaceuticals Inc.17patch; creamGeneric drugs (ANDA)November 1, 2018
Zydus Lifesciences Limited12patch; patch, extended releaseGeneric drugs (ANDA)November 2, 2023
Amneal Pharmaceuticals LLC11patch, extended release; tabletGeneric drugs (ANDA)September 30, 2020
Sandoz Inc11patch; patch, extended releaseAuthorized generics (NDA)December 22, 2014
Amneal Pharmaceuticals NY LLC10patch, extended releaseGeneric drugs (ANDA)September 30, 2020
Bryant Ranch Prepack10patch, extended release; gelGeneric drugs (ANDA)December 7, 2023
Noven Therapeutics, LLC10film, extended releaseAuthorized generics (NDA)January 1, 2018
Ani Pharmaceuticals, Inc.9gel; tabletGeneric drugs (ANDA)October 23, 2024
Bryant Ranch Prepack9tablet; creamGeneric drugs (ANDA)September 6, 2023
NorthStar RxLLC9gel; tabletGeneric drugs (ANDA)September 1, 2025
Bayer HealthCare Pharmaceuticals Inc.7patchNew drug applications (NDA)January 3, 2008
Encube Ethicals, Inc.7gel; creamGeneric drugs (ANDA)May 13, 2026
NuCare Pharmaceuticals,Inc.7tablet; creamGeneric drugs (ANDA)September 6, 2023
Zydus Pharmaceuticals USA Inc.7patchGeneric drugs (ANDA)November 2, 2023
Asclemed USA, Inc.6tabletGeneric drugs (ANDA)April 10, 2017
Bryant Ranch Prepack6insert; tabletGeneric drugs (ANDA)January 6, 2021
Padagis Israel Pharmaceuticals Ltd6gel; creamGeneric drugs (ANDA)December 7, 2023
Remedyrepack Inc.5tabletGeneric drugs (ANDA)November 22, 2023
Sandoz Inc5patch, extended releaseNew drug applications (NDA)January 8, 1999
Trigen Laboratories, LLC5gelNew drug applications (NDA)October 10, 2022
Vertical Pharmaceuticals, LLC5gelNew drug applications (NDA)December 17, 2019
Zydus Pharmaceuticals USA Inc.5patch, extended releaseGeneric drugs (ANDA)April 13, 2023
Direct_Rx3tabletGeneric drugs (ANDA)January 8, 2026
Epic Pharma, LLC3tabletGeneric drugs (ANDA)April 10, 2017
Northwind Health Company, LLC3tabletGeneric drugs (ANDA)February 15, 2023
PD-Rx Pharmaceuticals, Inc.3tabletGeneric drugs (ANDA)September 6, 2023
Preferred Pharmaceuticals Inc.3tabletGeneric drugs (ANDA)April 11, 2025
Puracap Laboratories LLC DBA Blu Pharmaceuticals3tabletGeneric drugs (ANDA)September 10, 2021
Redpharm Drug3cream; tabletGeneric drugs (ANDA)August 14, 2025
Teva Pharmaceuticals USA, Inc.3tabletGeneric drugs (ANDA)October 28, 1997
AvKARE2tablet; creamGeneric drugs (ANDA)February 16, 2021
Northwind Health Company, LLC2tabletGeneric drugs (ANDA)January 18, 2024
PharmPak, Inc.2tabletGeneric drugs (ANDA)July 9, 2019
Teva Pharmaceuticals USA, Inc.2insert; creamGeneric drugs (ANDA)January 2, 2018
Allergan, Inc.1creamGeneric drugs (ANDA)July 1, 2001
Alvogen Inc.1creamGeneric drugs (ANDA)March 5, 2018
American Health Packaging1tabletGeneric drugs (ANDA)May 2, 2025
Amneal Pharmaceuticals of New York LLC1insertGeneric drugs (ANDA)June 7, 2015
Ascend Therapeutics US, LLC1gel, meteredNew drug applications (NDA)February 9, 2004
Aurobindo Pharma Limited1tablet, film coatedGeneric drugs (ANDA)August 2, 2024
Coupler LLC1tabletGeneric drugs (ANDA)June 17, 2025
Glenmark Pharmaceuticals Inc., USA1tablet, film coatedGeneric drugs (ANDA)September 17, 2018
Novo Nordisk1insertNew drug applications (NDA)January 11, 2010
Nutritional Specialties, Inc.1sprayUnapproved homeopathic productsJuly 25, 2023
Padagis US LLC1sprayNew drug applications (NDA)April 11, 2015
Pfizer Laboratories Div Pfizer Inc1systemNew drug applications (NDA)June 5, 2023
Prasco Laboratories1creamGeneric drugs (ANDA)October 1, 2021
Professional Complementary Health Formulas1liquidUnapproved homeopathic productsAugust 15, 1984
Proficient Rx LP1tabletGeneric drugs (ANDA)October 28, 1997
Proficient Rx LP1tabletGeneric drugs (ANDA)September 6, 2023
Solaris Pharma Corporation1gelGeneric drugs (ANDA)January 28, 2026
Viatris Specialty LLC1gel, meteredNew drug applications (NDA)June 2, 2014

Dosage forms

Dosage formProductsShare
Tablet7429.6%
Patch4919.6%
Patch, extended release4518%
Gel3614.4%
Cream208%
Film, extended release114.4%
Insert52%
Tablet, film coated31.2%
Gel, metered31.2%
Spray20.8%
System10.4%
Liquid10.4%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)19979.6%
New drug applications (NDA)3212.8%
Authorized generics (NDA)176.8%
Unapproved homeopathic products20.8%

Pharmacologic classes

ClassProducts
Estrogen250

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.